Effect of Celecoxib Versus Placebo Before and After Knee Surgery on the Overall Use of Analgesics After Surgery

Study Overview
=================
Brief Summary
-----------------
To compare the total analgesic use at 24 hours after arthroscopic knee surgery in patients treated with celecoxib versus placebo.

Official Title
-----------------
A Double-blind, Placebo-Controlled, Randomized, Comparison Study of the Efficacy of Celebrex 400 mg Single Dose Pre and Celebrex 200 mg Post Ambulatory Arthroscopic Knee Surgery for Total Analgesic Use After Surgery

Conditions
-----------------
Arthroscopy

Intervention / Treatment
-----------------
* Drug: Celecoxib
* Other: Placebo


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion criteria: Diagnosed knee meniscus pathology requiring ambulatory arthroscopic meniscectomy or partial meniscectomy Willing to participate in study for 36 hours and come to follow-up visit 7 days post-surgery Exclusion criteria: Osteoarthritis, inflammatory arthritis, or previous fracture of index joint Received acetaminophen or low-dose narcotic within 8 hours of surgery Have received oral (4 weeks), intramuscular (2 months), intra-articular (3 months) or soft-tissue (2 months) injections of corticosteroids of the first dose of study medication or received intra-articular injections of hyaluronic acid in the index joint within 9 months of the first dose of study medication

Ages Eligible for Study
-----------------
Minimum Age: 18 Years
Maximum Age: 65 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Prevention
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Experimental: A<br> | Drug: Celecoxib<br>* 400 mg oral capsule as a single dose 1 hour prior to surgery and 200 mg oral capsule as a single dose as needed post-surgery<br>|
| Placebo Comparator: B<br> | Other: Placebo<br>* Matched placebo<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Total analgesic use after surgery |  | 24 hours | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Physical examination |  | Day 7 | 
| Number and percentage of subjects taking analgesic (hydrocodone bitartrate 5 mg/acetaminophen 500 mg [HC/APAP]) after surgery |  | 1, 2, 6, 8, 10, 12, 24, and 36 hours | 
| Time to analgesic use after surgery |  | 1, 2, 6, 8, 10, 12, 24, and 36 hours | 
| Cumulative number of HC/APAP tablets taken after first dose of study medication |  | 1, 2, 6, 8, 10, 12, 36 hours and Day 2 | 
| Vital signs |  | Day 7 | 
| Patient's Assessment of Knee Pain, according to visual analogue scale at rest and with movement after surgery |  | 1, 2, 6, 8, 10, 12, 24 and 36 hours | 
| Change in volumetric measurement of both knees from prior to surgery |  | Day 7 | 
| Patient Treatment Satisfaction Scales after surgery |  | 24 hours | 
| Adverse events |  | Day 7 | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Knee Surgery, Arthroscopic Surgery